期刊文献+

阿昔莫司对高脂血症兔主动脉壁脂蛋白脂肪酶表达的影响 被引量:1

Effects of acipimox on expression of lipoprotein lipase in aortic wall in rabbits with hyperlipidemia
下载PDF
导出
摘要 目的观察阿昔莫司对高脂血症兔主动脉壁脂蛋白脂肪酶表达的影响,探讨阿昔莫司抗动脉粥样硬化的机制。方法健康雄性新西兰大白兔30只,高脂饮食8周后,随机分为高脂组和阿昔莫司组,高脂组(10只),在高脂饮食基础上给予淀粉,阿昔莫司组(10只),在高脂饮食基础上给予阿昔莫司(50mg·kg-1·d-1);正常对照组(10只)给予普通饮食,共14周。采用免疫组织化学染色和半定量分析方法,观察阿昔莫司对主动脉壁脂蛋白脂肪酶表达的影响。结果阿昔莫司组14周后总胆固醇、低密度脂蛋白胆固醇和甘油三酯较高脂组分别下降41.8%、45.9%和46.1%(P均<0.01),高密度脂蛋白胆固醇明显上升(P<0.01);与高脂组相比,阿昔莫司组斑块面积减少1.69倍;阿昔莫司组可显著下调主动脉壁脂蛋白脂肪酶的表达。结论阿昔莫司可能通过下调动脉壁脂蛋白脂肪酶的表达而起到抗动脉粥样硬化作用。 Objective To investigate the effects of acipimox on expression of lipoprotein lipase (LPL) on aortic wall in rabbits with hyperlipidemia and the anti-atherogenic mechanisms. Methods Thirty male New Zealand white rabbits fed with 8-week lipid-rich diets were randomly assigned into hyperlipidemia group (n=10) to be fed with starch on the basis of lipid-rich diet for 6 weeks, and acipimox group (n=10) to be fed with aeipimox supplemented with lipid-rich diets (50 mg·kg^-1·d^-1) for 6 weeks. Control group (n=10) was fed with conventional diet for 14 weeks. The effects of aeipimox on LPL expression in aortie wall were determined via immunohistoehemistry assay and semiquantitative analysis. Results Aeipimox produced a decline in total cholesterol, low-density lipoprotein cholesterol and triglyceride by 41.8%, 45.9% and 46.1%, respectively (all P〈0.01). This was associated with an increase in high-density lipoprotein cholesterol (P〈0.01) as compared with hyperlipidemia group. Additionally, aeipimox yielded a 1.69- fold reduction in the surface area of atherosclerotie lesions (P〈0.01) and markedly down-regulated LPL expression in aortic wall. Conclusion The anti-atherogenie mechanisms of aeipimox may be related to down-regulation of LPL in aortic wall.
出处 《中国药物与临床》 CAS 2012年第6期717-719,共3页 Chinese Remedies & Clinics
基金 山西省卫生厅科技攻关计划项目(200922)
关键词 动脉粥样硬化 高脂血症 脂蛋白脂肪酶 阿昔莫司 Atheroselerosis Hyperlipidemia Rabbits Lipoproteinlipase Acipimox
  • 相关文献

参考文献8

  • 1Tsutsumi K. Lipoprotein lipase and atherosclerosis[J].Curr Vascu Pharm,2003,(01):11-17.
  • 2Ichikawa T,Liang J,Kitajima S. Macrophage-derived li-poprotein lipase increases aortic atherosclerosis in cholesterol-fed TG rabbits[J].Atheroclerosis,2005,(01):87-95.
  • 3余艳辉,瞿湘萍,李智,郭兆贵.兔高脂蛋白血症模型建立及动脉粥样斑块形成的方法学[J].中国药理学通报,1998,14(5):473-474. 被引量:29
  • 4Mattem J,Koomagi R,Volm M. Association of vascular endothe -lial growth factor expression with intratumoral microvessel densi -ty and tumor cell proliferation in human epidermoid lung carcinoma[J].British Journal of Cancer,1996,(07):931-934.
  • 5刘肖林,宓宝斌,石斗飞,毛艳华,马慧,闫晓红.阿西莫司治疗老年高脂血症疗效观察[J].山东医药,2007,47(34):53-54. 被引量:2
  • 6范文娟,赵水平,阳军.烟酸对高脂血症兔主动脉壁脂蛋白脂肪酶与三磷酸腺苷结合盒转运体A1表达的影响[J].中国动脉硬化杂志,2007,15(8):626-629. 被引量:3
  • 7Knowles HJ,Poele RT,Workman P. Niacin induces PPARgamma expression and transcriptional activation in macro-phages via HM74 and HM74 a-mediated induction of prostaglan-din synthesis pathways[J].Biochemical Pharmacology,2006,(05):646-656.
  • 8Gbaguidi FG,Chinetti G,Milossavljevic D. Peroxisome pro-liferator-activate d receptor (PPAR) agonists decrease lipopr otein lipase secretion and glycated LDL up take by human macrophages[J].FEBS Letters,2002,(1-3):85-90.

二级参考文献15

  • 1Tsutsumi K. Lipoprotein lipase and atherosclerosis [J]. Curt Vasc Pharmacol, 2003, 1 (1): 11-17.
  • 21chikawa T, Liang J, Kitajima S, Koike T, Wang X, Sun H, et al. Macrophage-derived lipoprotein lipase increases aortic atherosclerosis in cholesterol-fed .TG rabbits [J]. Atherosclerosis, 2005, 179 (1): 87-95.
  • 3Mattem J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung; carcinoma [J]. Brtish J Cancer, 1996, 73 (7) : 931- 934.
  • 4Meyers CD, Kamanna VS, Kashyap ML. Niacin ttherapy in atherosclerosis [J].Curr Opin Lipidol,2004,15 (6): 659-665.
  • 5Yla-Herttuala S, Lipton BA, Rnserfeld ME. Goldberg.IJ, Steinberg D. Witztum JL. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions [J]. Proc Natl Acad Sci USA. 1991, (22): 10 143-147.
  • 6Knowles HJ,te Poele RH,Workman P,Harris AL,Niacin induces PPARgamma expresion and transcriptional activation in macrophages via HM74 and HM74amediated induction of prostaglandin synthesis pathways[J].Biochem Pharmacol,2006,71(5):646-656.
  • 7Gbaguidi FG,Chinetti G,Milosavljevic D,Teissier E,Chapman J,Olivecrona G,et al.Peroxisome proliferator-activeated receptor(PPAR)agonists decrease lipoprotein lipase secretion and glycatde LDL uptake by human macrophages[J].FEBS Lett,2002,512(1-3):85-90.
  • 8Rubic T. Trottmann M, Lorenz RL. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin [J]. Biochem Pharmacol, 2004, 67 (3): 411-419.
  • 9Wang Y, Oram .JF. Unsaturated fatty acids inhibit cholesterol efflux from macroph-ages by increasing deggradation of ATP-binding cassette transporter A1 [J]. J Biol Chem, 2002, 277 (7): 5 692-697.
  • 10Stein Y,Stein O.Lipoprotein lipase and atherosclerosis[J].Atherosclerosis,2003,170(1):1-9.

共引文献31

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部